Financial statements Medilab
Balance sheet data of MEDILAB
Year
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|
Total assets | 44 123 178,27 | 42 876 036,52 | 40 344 381,39 | 42 875 218,06 |
A. Fixed assets | 1 902 832,18 | 2 423 378,06 | 2 961 303,98 | 3 012 199,65 |
B. Current assets | 42 220 346,09 | 40 452 658,46 | 37 383 077,41 | 39 863 018,41 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - |
D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 |
Total liabilities | 44 123 178,27 | 42 876 036,52 | 40 344 381,39 | 42 875 218,06 |
A. Equity | 37 149 836,01 | 37 202 247,69 | 34 125 518,53 | 33 066 395,87 |
B. Liabilities and provisions for liabilities | 6 973 342,26 | 5 673 788,83 | 6 218 862,86 | 9 808 822,19 |
I. Long-term liabilities | - | 240 703,95 | 202 212,39 | 219 154,03 |
II. Short-term liabilities | 6 102 966,65 | 4 731 766,81 | 5 396 042,86 | 9 019 333,45 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.